Supercharging synthetic biology for a sustainable future
Discover how Beckman Coulter Life Sciences is advancing synthetic biology research to tackle the challenges of our growing population
Discover how Beckman Coulter Life Sciences is advancing synthetic biology research to tackle the challenges of our growing population
Introducing hemolysis detection in point-of-care blood gas testing for the first time
Casgevy™ and Lyfgenia™ approvals pave the way for personalized gene editing therapies in treating sickle cell disease
In this free on-demand webinar, discover how a new AST technology helps clinical microbiology labs fast forward their results
Watch this on-demand webinar to learn how non-invasive monitoring programs can improve confidence in COVID-19 test results
Industry expert John Radke reveals how a reliable and transparent supply chain partner can be critical to weathering turbulent times
Initial findings showed that tocilizumab, a drug used to treat arthritis, was likely to improve outcomes among critically ill COVID-19 patients
Hybrid nanocapsules from renewable material hope to help cut carbon emissions
Are you looking to increase your team’s profitability and facilitate productivity? Check out this on-demand presentation for some expert advice
OMNIC Anywhere cloud-based sharing and data analysis application facilitates collaboration through 24/7 access to FTIR spectrometers data
The feasibility clinical study is designed to evaluate PRIMA sub-retinal implant in patients with atrophic dry age-related macular degeneration
DeNovix Inc. announces that the CellDrop™ Automated Cell Counter has been granted a patent by the Japanese Patent Office
The NovoCyte Advanteon Flow Cytometer is the first new product from the recently acquired ACEA Biosciences, and promises to be one of the most sensitive cell analyzers available
Improved optical sectioning delivers higher resolution without the need to acquire a z-stack
New nano3DX optimizes data acquisition enabling the measurement of volumes 25 times larger than other systems in a comparable time frame
Media allows two full-day breaks without changes to set up or protocol, increasing researcher schedule flexibility whilst reducing unnecessary variability in stem cell cultures.